Phase II study of oblimersen sodium and rituximab in patients with recurrent B-cell non-Hodgkin's lymphoma. Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Pro, B
  • Smith, MR
  • Leber, Brian
  • Younes, A
  • Fayad, L
  • Hagemeister, FB
  • McLaughlin, P
  • Rodriguez, AM
  • Caddick, Y
  • Zwiebel, JA

publication date

  • June 1, 2005